&nbsp;

Aug 2024

Drug

pegylated liposomal DOXOrubicin

Other Name(s): Caelyx®

Quick Link(s):

Sep 2025

Drug

PERTuzumab

Other Name(s): Perjeta®

Quick Link(s):

Sep 2022

Drug

pomalidomide

Other Name(s): Pomalyst®

Quick Link(s):

Apr 2025

Drug

ponatinib

Other Name(s): Iclusig®

Quick Link(s):

Aug 2023

Drug

pembrolizumab

Other Name(s): Keytruda®

Quick Link(s):

Sep 2025

Drug

lenvatinib

Other Name(s): Lenvima®

Quick Link(s):

Sep 2023

Drug

lanreotide

Other Name(s): Somatuline® Autogel®

Quick Link(s):

Jun 2024

Drug

liposomal irinotecan

Other Name(s): Onivyde® (Baxalta Canada)

Quick Link(s):

Sep 2017

Regimen

LETR

Cancer Type:

Breast

Intent: Adjuvant

Funding:

ODB - General Benefit

letrozole

, Collapse Show fewer tags

Drugs Used:

letrozole

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

LETR

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

letrozole

, Collapse Show fewer tags

Drugs Used:

letrozole

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

LENA

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria